Wu, Zeng et al. assess the feasibility and efficacy of AAV9:PKP2 gene therapy in the Pkp2-cKO mouse model of arrhythmogenic right ventricular cardiomyopathy. They show that it ameliorates ventricular arrhythmias, reverses adverse right ventricular remodeling, improves heart function, and reduces mortality in this mouse model.
- Iris Wu
- Aliya Zeng
- Zhihong Jane Yang